The BD Veritor™ Plus System

The power of simplicity:
the BD Veritor™ Plus System

As you navigate the ever-changing complexities of COVID-19 it is essential to have tools that minimize uncertainty. The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is engineered to make testing simple and reliable.

The BD Veritor™ Plus System The BD Veritor™ Plus System

Key testing components:1

  1. 1 BD Veritor™ Plus Analyzer
  2. 2 BD Veritor™ System SARS-CoV-2 Device
  3. 3 Sample collection swabs
  4. 4 BD Veritor™ System SARS-CoV-2 Extraction Reagent
  5. 5 Tube tray
  6. 6 Power cable
  7. 7 BD Veritor™ System SARS-CoV-2 positive (+) and negative (-) control swabs

Simplifying your COVID-19 testing

Handheld portability | BD Veritor™ Plus System

Portability lets you take testing to patients

  • Easy operation and one-button functionality
  • Cordless Analyzer allows the device to be taken to various locations
Simple sample collection | BD Veritor™ Plus System

Small, easy-to-use swab for simple sample collection

  • Mid-nasal (1-inch) insertion for less-invasive testing2
  • Dual side collection sample
  • 15-second sample preparation3
Fast, reliable results | BD Veritor™ Plus System

Fast, reliable results give you answers in real-time

  • Displays easy-to-read digital results for COVID-19 in 15 minutes: CoV2: (+) for positive, CoV2: (-) for negative
  • Records results on secured internal drive
  • Advanced particle technology helps improve test performance compared to visual read testing
Workflow efficiency | BD Veritor™ Plus System

Two workflow modes for testing that fits your needs

  • Analyze Now mode: Test device is inserted after incubation time is complete, allowing batches of samples to be tested (results in seconds)
  • Walk Away mode: Test device is inserted immediately into the Analyzer, so staff can multi-task while sample incubates (results in 15 minutes)
Infographic Infographic

Interpreting test results

It is important to understand how local disease prevalence rate and test performance characteristics interact to influence the proportion of false positive test results compared to all positive results. The infographic below demonstrates how very low, low, medium, and high prevalence rates make a difference. It is important to note that your institution’s specific prevalence rates can be used to calculate the potential in your facility. Understanding that false positive test results are a possibility is important. Please follow your institution and/or state and local guidance for addressing a patient with a positive test result. Guidance may include both precautionary isolation procedures and a second mode of testing for confirmation.

 

 

Hypothetical false positive rates based on prevalence

Infographic Infographic

Why false positives might occur

Even the most highly-accurate tests can produce false positive results. False positives are expected for all diagnostic tests, involving all detection technologies: PCR, antigen assays, etc. In the case of antigen tests (such as BD Veritor™ Plus System), test results could be influenced by a number of factors:

  • Workflow inconsistencies
  • Quality of test sample
  • Not following instructions for use

BD Veritor™ Plus System has a 98%-100% specificity, which means the false positive rate is less than 2% of all tests performed. This means, when you use your BD Veritor™ Plus System you might see 0-2 false positives for every 100 tests you conduct. If a customer sees rates of false positives higher than 2% of all tests performed, this would be outside of the performance we would expect. Any false positive should be reported to BD for further investigation. 

Key terms to understand
with COVID-19 testing

Understanding the specifics of test performance can be complex. Below is the list of test performance terminology which may help you to better understand. For additional information, review the fact sheet for healthcare providers.

  • Pretest Probability: Probability of a patient having an infection before the test result is known; based on the proportion of people in a community with the disease at a given time (prevalence) and the clinical presentation of the patient.
  • Negative Predictive Value: Probability that a patient who has a negative test result truly does not have the infection.
  • Positive Predictive Value: Probability that a patient who has a positive test result truly does have the infection.
  • False Positive Result: A test result indicating the infection is present when it is not.
  • True Negative Result: A test result correctly indicating that the infection is not present.
  • False Negative Result: A test result indicating the infection is not present when it is.
  • True Positive Result: A test result correctly indicating that the infection is present.

 

Learn more about prevalence rates and testing outcomes:

Learn more about interim guidance for rapid antigen testing for SARS-CoV-2:

Citations
  1. BD Veritor™ System for Rapid Detection of SARS-CoV-2 Instructions for Use, package insert. Franklin Lakes, NJ: Becton, Dickinson and Company.
  2. https://www.cdc.gov/coronavirus/2019-ncov/downloads/OASH-nasal-specimen-collection-fact-sheet.pdf
  3. BD Veritor™ System for Rapid Detection of SARS-CoV-2 Quick Reference Instructions. Franklin Lakes, NJ: Becton, Dickinson and Company.
  4. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html#table2